These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2632000)

  • 1. [Thymosin fraction 5. Preclinical study].
    Panajotovová V; Lastovicka J; Sůla K; Nouza K; Pokorná D; Grimová J
    Cas Lek Cesk; 1989 Dec; 128(51):1615-20. PubMed ID: 2632000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunomodulatory effect of Consupren Sol. Spofa (cyclosporin A). Preclinical study].
    Panajatovová V; Lastovicka J; Grimová J
    Cesk Farm; 1991 Nov; 40(4-5):162-6. PubMed ID: 1821331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymosin: an immunomodulator of antibody production in man.
    Górski A; Korczak-Kowalska G; Nowaczyk M; Gaciong Z; Skopińska-Rózewska E
    Immunology; 1982 Nov; 47(3):497-501. PubMed ID: 6215339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of action of thymosin. I. Thymosin fraction 5 increases lymphokine production by mature murine T cells responding in a mixed lymphocyte reaction.
    Zatz MM; Goldstein AL
    J Immunol; 1985 Feb; 134(2):1032-8. PubMed ID: 3155533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production and characterization of a bovine T cell-specific monoclonal antibody identifying a mature differentiation antigen.
    Rabinovsky ED; Yang TJ
    J Immunol; 1986 Jan; 136(2):609-15. PubMed ID: 3079788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro induction of Lyt surface markers on precursor cells incubated with thymosin polypeptides.
    Ahmed A; Smith AH; Wong DM; Thurman GB; Goldstein AL; Sell KW
    Cancer Treat Rep; 1978 Nov; 62(11):1739-47. PubMed ID: 310340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective thymic education of L3T4+ T helper cell function in graft-vs-host mice.
    Fukuzawa M; Via CS; Shearer GM
    J Immunol; 1988 Jul; 141(2):430-9. PubMed ID: 2968400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The biological effect of three thymosin fraction 5 polypeptides in the murine mixed lymphocyte reaction.
    Baxevanis CN; Perez S; Kokkinopoulos D; Papamichail M
    Immunology; 1985 Apr; 54(4):723-30. PubMed ID: 3156810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymus lymphocytes in rats during induction of bladder tumors and effects of thymosin fraction 5 in vitro.
    Wada S; Ozaki Y; Nishio S; Maekawa M; Kimura S; Kinoshita Y
    J Natl Cancer Inst; 1985 Mar; 74(3):659-64. PubMed ID: 3856067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo generation of suppressor T cells by thymosin in congenitally athymic nude mice.
    Marshall GD; Thurman GB; Rossio JL; Goldstein AL
    J Immunol; 1981 Feb; 126(2):741-4. PubMed ID: 6161188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vivo modulation of thymus-derived lymphocytes with monoclonal antibodies in mice. I. Effect of anti-Thy-1 antibody on the tissue distribution of lymphocytes.
    Le Gros GS; Prestidge RL; Watson JD
    Immunology; 1983 Dec; 50(4):537-46. PubMed ID: 6606612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of chronic lymphocytic leukemia (CLL) lymphocyte phenotypes by in vitro incubation with alpha 1 thymosin.
    Benković B; Burek B; Jaksić B; Vitale B
    Blood Cells; 1987; 12(2):441-55. PubMed ID: 3304472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoration of T-cell function and induction of antitumor immune response in T-cell-depressed spontaneously hypertensive rats by treatment with thymosin fraction 5.
    Takeichi N; Koga Y; Fujii T; Kobayashi H
    Cancer Res; 1985 Feb; 45(2):487-91. PubMed ID: 3871352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the mechanisms of action of the immunomodulator Bestatin in various screening test systems.
    Schorlemmer HU; Bosslet K; Dickneite G; Lüben G; Sedlacek HH
    Behring Inst Mitt; 1984 May; (74):157-73. PubMed ID: 6383322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental immunological screening tests on pidotimod.
    Coppi G; Manzardo S
    Arzneimittelforschung; 1994 Dec; 44(12A):1411-6. PubMed ID: 7857333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Modulation of suppressor activity by thymosin].
    Cupissol D; Thierry C; Serrou B
    C R Seances Soc Biol Fil; 1981; 175(2):235-41. PubMed ID: 6454471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease.
    Via CS; Sharrow SO; Shearer GM
    J Immunol; 1987 Sep; 139(6):1840-9. PubMed ID: 2957440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo.
    Truitt RL; Shih CY; Lefever AV; Tempelis LD; Andreani M; Bortin MM
    J Immunol; 1983 Oct; 131(4):2050-8. PubMed ID: 6194224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental autoimmune thyroiditis: modulation of the disease level in high and low responder mice by thymosin.
    Tomazic V; Suter CM; Chretien PB
    Clin Exp Immunol; 1984 Oct; 58(1):83-9. PubMed ID: 6478652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to L1210 mouse leukemia cells in moderately protein-malnourished BALB/c mice treated in vivo with thymosin fraction V.
    Petro TM; Watson RR
    Cancer Res; 1982 Jun; 42(6):2139-45. PubMed ID: 6804089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.